.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Deloitte
Colorcon
Dow
Julphar
Harvard Business School
Chubb
Cipla
Argus Health
Express Scripts

Generated: June 26, 2017

DrugPatentWatch Database Preview

Mefloquine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mefloquine hydrochloride and what is the scope of mefloquine hydrochloride freedom to operate?

Mefloquine hydrochloride
is the generic ingredient in two branded drugs marketed by West-ward Pharms Int, Sandoz, Us Army Walter Reed, Roche, Barr, and Hikma Intl Pharms, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for mefloquine hydrochloride. Seven suppliers are listed for this compound.

Summary for Generic Name: mefloquine hydrochloride

Tradenames:2
Patents:1
Applicants:6
NDAs:6
Drug Master File Entries: see list6
Suppliers / Packagers: see list7
Bulk Api Vendors: see list38
Clinical Trials: see list2,304
Patent Applications: see list1,071
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mefloquine hydrochloride at DailyMed

Pharmacology for Ingredient: mefloquine hydrochloride

Drug ClassAntimalarial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army Walter Reed
MEFLOQUINE HYDROCHLORIDE
mefloquine hydrochloride
TABLET;ORAL019578-001May 2, 1989DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
MEFLOQUINE HYDROCHLORIDE
mefloquine hydrochloride
TABLET;ORAL076523-001Oct 1, 2004ABRXNoNo► Subscribe► Subscribe
Hikma Intl Pharms
MEFLOQUINE HYDROCHLORIDE
mefloquine hydrochloride
TABLET;ORAL077699-001Apr 21, 2010DISCNNoNo► Subscribe► Subscribe
Roche
LARIAM
mefloquine hydrochloride
TABLET;ORAL019591-001May 2, 1989DISCNNoNo► Subscribe► Subscribe
Sandoz
MEFLOQUINE HYDROCHLORIDE
mefloquine hydrochloride
TABLET;ORAL076175-001Feb 20, 2002DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mefloquine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
LARIAM
mefloquine hydrochloride
TABLET;ORAL019591-001May 2, 19894,579,855► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Fish and Richardson
McKinsey
Deloitte
Chubb
AstraZeneca
Fuji
Julphar
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot